Work

A randomized, phase II study of pazopanib in castrate-sensitive prostate cancer: a University of Chicago Phase II Consortium/Department of Defense Prostate Cancer Clinical Trials Consortium study

Year: 2011

Type: article

Study design: Clinical Trial

Source: Prostate Cancer and Prostatic Diseases

DOI: 10.1038/pcan.2011.49

Authors: J E Ward, T Karrison, G Chatta, M Hussain, D Shevrin, R Z Szmulewitz, P H O'Donnell, W M Stadler, E M Posadas

Institutions: University of Chicago, University of Pittsburgh, University of Michigan, Endeavor Health, Cedars-Sinai Medical Center

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: U.S. Department of Defense, National Institutes of Health, National Cancer Institute

Awards: G1964418830, G371985182, Early Therapeutics Development with Phase II Emphasis, G980112651

OpenAlex ID: W2050263735

FWCI: 2.473

Cites: 32

Cited by: 19

Related to: 10